Source: University at Buffalo, The State University of New York
Date: January 9, 2006
Summary:
BUFFALO, N.Y. -- For diabetes patients, human stem cell-based transplants that produce insulin would be a major breakthrough. Emmanuel (Manolis) Tzanakakis, Ph.D., is striving to boost the numbers of stem cells produced in the laboratory, expanding the pool of cells that eventually can be differentiated into insulin-producing cells.
No comments:
Post a Comment